1.Clinical and Mycological Studies on Dermatophytosis.
Byoung Keun MIN ; Byoung Soo CHUNG ; Kyu Cherl CHOI ; Hyoung Kyun KIM
Korean Journal of Dermatology 1984;22(6):604-609
No abstract available.
Tinea*
2.A Case of Recalcitrant Tinea Pedis caused by Trichosporon asahii.
Tae Hoon KIM ; Jeong Wan SEO ; Seung Hwan CHOI ; Ki Hoon SONG ; Ki Ho KIM
Korean Journal of Medical Mycology 2016;21(3):98-100
No abstract available.
Tinea Pedis*
;
Tinea*
;
Trichosporon*
3.A Case of Infantile Tinea Capitis Treated with Oral Fluconazole.
Soo Hyeon NOH ; Ga Hye NA ; Jin Kyung CHAE ; Kun PARK ; Eun Jung KIM
Korean Journal of Dermatology 2017;55(8):539-540
No abstract available.
Fluconazole*
;
Tinea Capitis*
;
Tinea*
4.A randomized, double-blind, controlled trial on the efficacy and safety of 1.5% Carica Papaya Latex Cream compared to 1% Terbinafine Cream in the treatment of localized Tinea Corporis and/or Tinea Cruris
Marisel P. Abejo ; Vesna Castillo-Yaptinchay ; Jesusa Barcelona-Tan
Journal of the Philippine Medical Association 2017;95(2):40-47
Background:
Tinea corporis and cruris are superficial fungal infections mainly caused by dermatophytes. The antifungal effect of carica papaya latex cream has been demonstrated in clinical studies, however, larger population and comparative studies to standard antifungal agents are needed to further strengthen this conclusion. This study determined the efficacy and safety of 1.5% carica papaya latex in cream base as treatment for tinea corporis and/or cruris compared to 1% terbinafine cream.
Methods:
This is a randomized, double-blind controlled trial wherein subjects with a clinical diagnosis of tinea corporis or cruris confirmed by microscopy applied terbinafine or carica papaya latex cream twice daily for 6 weeks. The efficacy and safety were assessed 2, 4, and 6 weeks using clinical and mycological cure parameters. The incidence of adverse effects was likewise evaluated.
Results:
90 subjects were randomized, 45 in carica papaya group and 45 in the terbinafine group. Both groups had statistically comparable improvements based on symptoms and mycological cure rates. Adverse events are significantly higher in the papaya latex cream group.
Conclusion
Carica papaya latex cream is as effective as terbinafine cream in the treatment of tinea corporis and/or cruris, but it has a higher incidence of adverse events.
Terbinafine
;
Tinea cruris
;
Tinea
5.Histopathologically Confirmed Tinea Capitis Misdiagnosed as Psoriasis.
Barnali CHOWDHURY ; Osung KWON ; Hyungrok KIM ; Hyunjung KWON ; Kyungduck PARK ; Hyun CHUNG ; Joonsoo PARK
Korean Journal of Medical Mycology 2016;21(4):135-137
No abstract available.
Psoriasis*
;
Tinea Capitis*
;
Tinea Favosa
;
Tinea*
6.Porokeratosis Ptychotropica Coexisting with Tinea Corporis.
Solam LEE ; Sung Jay CHOE ; Sung Ku AHN
Annals of Dermatology 2017;29(4):506-508
No abstract available.
Porokeratosis*
;
Tinea*
7.'Clues' for the Histological Diagnosis of Tinea: How Reliable Are They?.
Young Woon PARK ; Dong Young KIM ; So Young YOON ; Gyeong Yul PARK ; Hyun Sun PARK ; Hyun Sun YOON ; Soyun CHO
Annals of Dermatology 2014;26(2):286-288
No abstract available.
Diagnosis*
;
Tinea*
8.Tinea Incognito Simulating Herpes Simplex Virus Infection.
Young Woon PARK ; Jae Woo CHOI ; Seung Hwan PAIK ; Dong Young KIM ; Seon Pil JIN ; Hyun Sun PARK ; Hyun Sun YOON ; Soyun CHO
Annals of Dermatology 2014;26(2):267-269
No abstract available.
Simplexvirus*
;
Tinea*
9.A case of tinea corporis caused by diffusible pigment producing trichophyton rubrum.
Ki Hong KIM ; Yong Myo PARK ; Jong Cheol KIM ; Jong Soo CHOI
Korean Journal of Dermatology 1991;29(4):529-532
No abstract available.
Tinea*
;
Trichophyton*
10.Senna alata (akapulko) extract versus topical antifungals for treatment of superficial fungal skin infections: A systematic review and meta-analysis.
Erin Jane L. TABABA ; Rowena Natividad S. FLORES-GENUINO ; Charissa Mia D. SALUD-GNILO
Acta Medica Philippina 2020;54(1):45-52
OBJECTIVE: The study aimed to assess the efficacy and safety of Senna alata (akapulko) plant extracts compared with topical antifungals in the treatment of superficial fungal skin infections.
METHODS: A systematic review and meta-analysis of randomized controlled trials that studied patients with diagnosed cutaneous tinea or dermatophytosis (excluding hair and nail), tinea versicolor, or cutaneous candidiasis, via microscopy or culture, and compared the efficacy and safety of S. alata (akapulko) extract versus topical antifungals. Two authors independently screened titles and abstracts of merged search results from electronic databases (The Cochrane Skin Group Specialized Register, CENTRAL, MEDLINE, EMBASE (January 1990 to December 2011), Health Research and Development Information Network (HERDIN), and reference lists of articles), assessed eligibility, assessed the risk of bias using the domains in the Cochrane Risk Bias tool and collected data using a pretested Data extraction form (DEF). Meta-analyses were performed when feasible.
RESULTS: We included seven RCTs in the review. There is low certainty of evidence that S. alata 50% lotion is as efficacious as sodium thiosulfate 25% lotion (RR 0.91, 95% CI, 0.79 to 1.04; 4 RCTs, n=216; p=0.15; I2=52%) and high quality evidence that S. alata cream is as efficacious as ketoconazole (RR 0.95, 95% CI, 0.82 to 1.09; 1 RCT, n=40; p=0.44) and terbinafine cream (RR 0.93, 95% CI, 0.86 to 1.01; 1 RCT, n=150; p=0.09) in mycologic cure. For adverse effects, there is very low certainty of evidence of increased harm with S. alata 50% lotion compared to sodium thiosulfate 25% lotion (RR 1.26, 95% CI, 0.46, 3.44; 2 RCTs, n=120; p=0.65; I2=19%). Adverse effects were few and mild.
CONCLUSION: S. Alata 50% lotion may be as efficacious as sodium thiosulfate 25% lotion and is as efficacious as ketoconazole 2% and terbinafine 1% creams. There is insufficient evidence to compare the safety of S. alata 50% lotion with sodium thiosulfate 25% lotion.
Tinea Versicolor